FRX : Fennec Pharmaceuticals Inc Stock Profile

Last Updated: 3/12/2024 0:47:16

Fennec Pharmaceuticals Inc trades with the ticker FRX on the TSX and is in the Biotechnology industry.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company’s product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Looking to invest in Fennec Pharmaceuticals Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.

FRX.TO Stock Price and Key Stats

ETF Key Stats

Exchange: TSX

Market Cap : $352.565MM

PE Ratio:

Price: 13.2 (Updated: 3/12/2024 0:47:16)

Fennec Pharmaceuticals Inc (FRX) vs Competitors in Biotechnology

Lets see how FRX.TO stacks up against others in the Biotechnology asset management industry. We have identified its main peers as:

Aeterna Zentaris Inc, Aptose Biosciences Inc, BELLUS Health Inc, IMV Inc, Intellipharmaceutics International Inc


Biotechnology Industry Comparisons

Company Market Cap ($MM) P/E Ratio EV/EBITDA Dividend Yield
Aeterna Zentaris Inc (AEZS) $12.674 N/A 1.709 N/A%
Aptose Biosciences Inc (APS) $33.927 N/A -0.231 N/A%
BELLUS Health Inc (BLU) $2,470.298 N/A -16.428 0.0%
Fennec Pharmaceuticals Inc (FRX) $352.565 N/A -21.793 N/A%
IMV Inc (IMV) $13.117 N/A -0.843 0.0%

EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield  

Comparisons within Biotechnology

  • Fennec Pharmaceuticals Inc (FRX) vs Aeterna Zentaris Inc (AEZS)
    • FRX has higher EPS (-1.01 vs -6.47). AEZS and FRX both have P/E’s under 0.
  • Fennec Pharmaceuticals Inc (FRX) vs Aptose Biosciences Inc (APS)
    • FRX has higher EPS (-1.01 vs -10.45). APS and FRX both have P/E’s under 0.
  • Fennec Pharmaceuticals Inc (FRX) vs BELLUS Health Inc (BLU)
    • BLU has higher EPS (-0.96 vs -1.01). BLU provides dividends, while FRX does not. BLU and FRX both have P/E’s under 0.
  • Fennec Pharmaceuticals Inc (FRX) vs IMV Inc (IMV)
    • FRX has higher EPS (-1.01 vs -6.11). IMV provides dividends, while FRX does not. IMV and FRX both have P/E’s under 0.
  • Fennec Pharmaceuticals Inc (FRX) vs Intellipharmaceutics International Inc (IPCI)
    • IPCI has higher EPS (-0.12 vs -1.01). IPCI and FRX both have P/E’s under 0.

Our Recommendation: Hold
Features a lower EV/EBITDA ratio (-21.79) than the industry average (-4.03), indicating attractive valuation.

How to Buy FRX stock on the TSX

You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:

ImageProduct TitleFeaturesPrice
Editor's Choice
Wealthsimple Trade

Wealthsimple Trade

  • ETF buys and sells have $0 trading fees
  • Desktop and mobile trading
  • Reputable Brand
  • Beautiful Design
Get $25 Signup Bonus
Reliable Pick


  • ETF buys have $0 trading fees
  • Desktop and mobile trading
  • Most types of accounts available
Get $50 Free Stock Trades
Photo of author
Author Bio - Qayyum Rajan is a CFA Charterholder with 10+ years of finance experience and the co-creator of He has previously worked as a portfolio manager at RBC Dominion Securities and other roles at asset managers like Sentry Investments. He then started building websites and fintech apps to bring finance to everyone.

Check Out These Posts:

Leave a Comment